Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Current Medical Research and Opinion
|
February 2, 2026
Precisely imprecise: therapeutic misconception in precision oncology trials
Samuel Gordon, Katarzyna Klas, Marcin Waligora
Expert Review of Clinical Pharmacology
|
May 6, 2026
Factors to consider when designing clinical trials for repurposed drugs
Samuel Gordon, Katarzyna Klas, Marcin Waligora
Medicine, Health Care, and Philosophy
|
March 7, 2023
Ethical challenges of clinical trials with a repurposed drug in outbreaks
Katarzyna Klas, Karolina Strzebonska, Marcin Waligora
Current Medical Research and Opinion
|
September 29, 2023
Bioethics of somatic gene therapy: what do we know so far?
Paola Buedo, Alahi Bianchini, Katarzyna Klas, et al.
Plos One
|
January 21, 2022
How informative were early SARS-CoV-2 treatment and prevention trials? a longitudinal cohort analysis of trials registered on ClinicalTrials.gov
Nora Hutchinson, Katarzyna Klas, Benjamin G Carlisle, et al.
BMC Research Notes
|
December 12, 2022
Competition for recruitment in SARS-CoV-2 Trials in the United States: a longitudinal cohort analysis
Nora Hutchinson, Katarzyna Klas, Benjamin G Carlisle, et al.
Plos One
|
December 3, 2024
Seamless trials in oncology: A cross-sectional analysis of characteristics and reporting
Katarzyna Klas, Karolina Strzebonska, Paola Buedo, et al.
Targeted Oncology
|
October 25, 2024
Risk and Benefit for Basket Trials in Oncology: A Systematic Review and Meta-Analysis
Katarzyna Klas, Karolina Strzebonska, Lucja Zaborowska, et al.
Journal of Clinical Epidemiology
|
February 3, 2025
Results reporting for clinical trials led by medical universities and university hospitals in the nordic countries was often missing or delayed
Gustav Nilsonne, Susanne Wieschowski, Nicholas J DeVito, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Current Medical Research and Opinion
|
February 2, 2026
Precisely imprecise: therapeutic misconception in precision oncology trials
Samuel Gordon, Katarzyna Klas, Marcin Waligora
Expert Review of Clinical Pharmacology
|
May 6, 2026
Factors to consider when designing clinical trials for repurposed drugs
Samuel Gordon, Katarzyna Klas, Marcin Waligora
Medicine, Health Care, and Philosophy
|
March 7, 2023
Ethical challenges of clinical trials with a repurposed drug in outbreaks
Katarzyna Klas, Karolina Strzebonska, Marcin Waligora
Current Medical Research and Opinion
|
September 29, 2023
Bioethics of somatic gene therapy: what do we know so far?
Paola Buedo, Alahi Bianchini, Katarzyna Klas, et al.
Plos One
|
January 21, 2022
How informative were early SARS-CoV-2 treatment and prevention trials? a longitudinal cohort analysis of trials registered on ClinicalTrials.gov
Nora Hutchinson, Katarzyna Klas, Benjamin G Carlisle, et al.
BMC Research Notes
|
December 12, 2022
Competition for recruitment in SARS-CoV-2 Trials in the United States: a longitudinal cohort analysis
Nora Hutchinson, Katarzyna Klas, Benjamin G Carlisle, et al.
Plos One
|
December 3, 2024
Seamless trials in oncology: A cross-sectional analysis of characteristics and reporting
Katarzyna Klas, Karolina Strzebonska, Paola Buedo, et al.
Targeted Oncology
|
October 25, 2024
Risk and Benefit for Basket Trials in Oncology: A Systematic Review and Meta-Analysis
Katarzyna Klas, Karolina Strzebonska, Lucja Zaborowska, et al.
Journal of Clinical Epidemiology
|
February 3, 2025
Results reporting for clinical trials led by medical universities and university hospitals in the nordic countries was often missing or delayed
Gustav Nilsonne, Susanne Wieschowski, Nicholas J DeVito, et al.
Page
of 1